FORT WORTH, Texas, Jan. 21 ... has granted Fast Track designation to NPI-001 (N-acetylcysteine amide) tablets, Nacuity’s proprietary investigational therapy for the treatment of patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback